Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
Key | |
---|---|
Module Score | Databases |
![]() | Where interaction is observed in another database a link is provided: |
Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
---|---|---|---|---|---|---|---|---|---|
![]() | ![]() | ![]() | ![]() | ||||||
DAB1 | PRKCA | PRKCA, PKCA, PRKACA: Protein kinase C alpha type | 4.84E3 | Evidence | |||||
DAB1 | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 61.60 | Evidence | |||||
DAB1 | PRKCE | PRKCE, PKCE: Protein kinase C epsilon type | 45.90 | Evidence | |||||
DAB1 | ACVR1B | ACVR1B, ACVRLK4: Activin receptor type-1B precursor | 40.60 | Evidence | |||||
DAB1 | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 25.3 | Evidence | |||||
DAB1 | KIT | KIT: Mast/stem cell growth factor receptor precursor | 14.60 | Evidence | |||||
DAB1 | PDGFRA | PDGFRA: Alpha-type platelet-derived growth factor receptor precursor | 14.60 | Evidence | |||||
DAB1 | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 14.60 | Evidence | |||||
DAB1 | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 11.60 | Evidence | |||||
DAB1 | MAPK1 | MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 | 11.60 | Evidence | |||||
DAB1 | MAPK3 | MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 | 10.40 | Evidence | |||||
DAB1 | SOS1 | SOS1: Son of sevenless homolog 1 | 10.40 | Evidence | |||||
DAB1 | INSR | INSR: Insulin receptor precursor | 10.10 | Evidence | |||||
DAB1 | CTTN | CTTN, EMS1: Src substrate cortactin | 9.89 | Evidence | |||||
DAB1 | SH2D2A | SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A | 9.89 | Evidence | |||||
DAB1 | LCP2 | LCP2: Lymphocyte cytosolic protein 2 | 8.92 | Evidence | |||||
DAB1 | ABL1 | ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 | 8.92 | Evidence | |||||
DAB1 | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 8.86 | Evidence | |||||
DAB1 | FGR | FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR | 7.99 | Evidence | |||||
DAB1 | SYK | SYK: Tyrosine-protein kinase SYK | 7.99 | Evidence | |||||
DAB1 | SMAD3 | SMAD3, MADH3: Mothers against decapentaplegic homolog 3 | 6.18 | Evidence | |||||
DAB1 | BCAR1 | BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 | 5.50 | Evidence | |||||
DAB1 | WAS | WAS, IMD2: Wiskott-Aldrich syndrome protein | 5.29 | Evidence | |||||
DAB1 | WASPIP | N/A | 5.29 | Evidence | |||||
DAB1 | ACVR2A | ACVR2A, ACVR2: Activin receptor type-2A precursor | 5.14 | Evidence | |||||
DAB1 | WASL | WASL: Neural Wiskott-Aldrich syndrome protein | 4.47 | Evidence | |||||
DAB1 | SHC3 | SHC3, NSHC, SHCC: SHC-transforming protein 3 | 2.13 | Evidence | |||||
DAB1 | DVL2 | DVL2: Segment polarity protein dishevelled homolog DVL-2 | 1.32 | Evidence |